This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hestermann, E. V.
Right arrow Articles by Brown, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hestermann, E. V.
Right arrow Articles by Brown, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2003, p. 7920-7925, Vol. 23, No. 21
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.21.7920-7925.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Agonist and Chemopreventative Ligands Induce Differential Transcriptional Cofactor Recruitment by Aryl Hydrocarbon Receptor

Eli V. Hestermann{dagger} and Myles Brown*

Department of Molecular Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Received 23 April 2003/ Returned for modification 7 July 2003/ Accepted 5 August 2003

Aryl hydrocarbon receptor (AHR) is a transcription factor whose activity is regulated by environmental agents, including several carcinogenic agonists. We measured recruitment of AHR and associated proteins to the human cytochrome P4501A1 gene promoter in vivo. Upon treatment with the agonist ß-naphthoflavone, AHR is rapidly associated with the promoter and recruits the three members of the p160 family of coactivators as well as the p300 histone acetyltransferase, leading to recruitment of RNA polymerase II (Pol II) and induction of gene transcription. AHR, coactivators, and Pol II cycle on and off the promoter, with a period of ~60 min. In contrast, the chemopreventative AHR ligand 3,3'-diindolylmethane promotes AHR nuclear translocation and p160 coactivator recruitment but, remarkably, fails to recruit Pol II or cause histone acetylation. This novel mechanism of receptor antagonism may account for the antitumor properties of chemopreventative compounds targeting the AHR.


* Corresponding author. Mailing address: 44 Binney St., D730, Boston, MA 02115. Phone: (617) 632-3948. Fax: (617) 632-5417. E-mail: Myles_Brown{at}dfci.harvard.edu.

{dagger} Present address: Biology Department, Furman University, Greenville, SC 29613.


Molecular and Cellular Biology, November 2003, p. 7920-7925, Vol. 23, No. 21
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.21.7920-7925.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Swanick, S., Windstar-Hamlin, K., Zwickey, H. (2009). An Alternative Treatment for Cervical Intraepithelial Neoplasia II, III. Integr Cancer Ther 8: 164-167 [Abstract]  
  • Wihlen, B., Ahmed, S., Inzunza, J., Matthews, J. (2009). Estrogen Receptor Subtype- and Promoter-Specific Modulation of Aryl Hydrocarbon Receptor-Dependent Transcription. Mol Cancer Res 7: 977-986 [Abstract] [Full Text]  
  • Bass, S. E., Sienkiewicz, P., MacDonald, C. J., Cheng, R. Y.S., Sparatore, A., Del Soldato, P., Roberts, D. D., Moody, T. W., Wink, D. A., Yeh, G. C. (2009). Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells. Clin. Cancer Res. 15: 1964-1972 [Abstract] [Full Text]  
  • Okino, S. T., Pookot, D., Basak, S., Dahiya, R. (2009). Toxic and Chemopreventive Ligands Preferentially Activate Distinct Aryl Hydrocarbon Receptor Pathways: Implications for Cancer Prevention. Cancer Prevention Research 2: 251-256 [Abstract] [Full Text]  
  • Taylor, R. T., Wang, F., Hsu, E. L., Hankinson, O. (2009). Roles of Coactivator Proteins in Dioxin Induction of CYP1A1 and CYP1B1 in Human Breast Cancer Cells. Toxicol Sci 107: 1-8 [Abstract] [Full Text]  
  • Degner, S. C., Papoutsis, A. J., Selmin, O., Romagnolo, D. F. (2009). Targeting of Aryl Hydrocarbon Receptor-Mediated Activation of Cyclooxygenase-2 Expression by the Indole-3-Carbinol Metabolite 3,3'-Diindolylmethane in Breast Cancer Cells. J. Nutr. 139: 26-32 [Abstract] [Full Text]  
  • Baglole, C. J., Maggirwar, S. B., Gasiewicz, T. A., Thatcher, T. H., Phipps, R. P., Sime, P. J. (2008). The Aryl Hydrocarbon Receptor Attenuates Tobacco Smoke-induced Cyclooxygenase-2 and Prostaglandin Production in Lung Fibroblasts through Regulation of the NF-{kappa}B Family Member RelB. J. Biol. Chem. 283: 28944-28957 [Abstract] [Full Text]  
  • Haarmann-Stemmann, T., Bothe, H., Kohli, A., Sydlik, U., Abel, J., Fritsche, E. (2007). Analysis of the Transcriptional Regulation and Molecular Function of the Aryl Hydrocarbon Receptor Repressor in Human Cell Lines. Drug Metab. Dispos. 35: 2262-2269 [Abstract] [Full Text]  
  • Okino, S. T., Quattrochi, L. C., Pookot, D., Iwahashi, M., Dahiya, R. (2007). A Dioxin-Responsive Enhancer 3' of the Human CYP1A2 Gene. Mol. Pharmacol. 72: 1457-1465 [Abstract] [Full Text]  
  • Li, G., Leff, T. (2007). Altered Promoter Recycling Rates Contribute to Dominant-Negative Activity of Human Peroxisome Proliferator-Activated Receptor-{gamma} Mutations Associated with Diabetes. Mol. Endocrinol. 21: 857-864 [Abstract] [Full Text]  
  • Pollenz, R. S., Wilson, S. E., Dougherty, E. J. (2006). Role of Endogenous XAP2 Protein on the Localization and Nucleocytoplasmic Shuttling of the Endogenous Mouse Ahb-1 Receptor in the Presence and Absence of Ligand. Mol. Pharmacol. 70: 1369-1379 [Abstract] [Full Text]  
  • N'Diaye, M., Le Ferrec, E., Lagadic-Gossmann, D., Corre, S., Gilot, D., Lecureur, V., Monteiro, P., Rauch, C., Galibert, M.-D., Fardel, O. (2006). Aryl Hydrocarbon Receptor- and Calcium-dependent Induction of the Chemokine CCL1 by the Environmental Contaminant Benzo[a]pyrene. J. Biol. Chem. 281: 19906-19915 [Abstract] [Full Text]  
  • Hockings, J. K., Thorne, P. A., Kemp, M. Q., Morgan, S. S., Selmin, O., Romagnolo, D. F. (2006). The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen. Cancer Res. 66: 2224-2232 [Abstract] [Full Text]  
  • Abdelrahim, M., Ariazi, E., Kim, K., Khan, S., Barhoumi, R., Burghardt, R., Liu, S., Hill, D., Finnell, R., Wlodarczyk, B., Jordan, V. C., Safe, S. (2006). 3-Methylcholanthrene and Other Aryl Hydrocarbon Receptor Agonists Directly Activate Estrogen Receptor {alpha}. Cancer Res. 66: 2459-2467 [Abstract] [Full Text]  
  • Pollenz, R. S., Dougherty, E. J. (2005). Redefining the Role of the Endogenous XAP2 and C-terminal hsp70-interacting Protein on the Endogenous Ah Receptors Expressed in Mouse and Rat Cell Lines. J. Biol. Chem. 280: 33346-33356 [Abstract] [Full Text]  
  • Matthews, J., Wihlen, B., Thomsen, J., Gustafsson, J.-A. (2005). Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor {alpha} to 2,3,7,8-Tetrachlorodibenzo- p-Dioxin-Responsive Promoters. Mol. Cell. Biol. 25: 5317-5328 [Abstract] [Full Text]  
  • Bonzo, J. A., Chen, S., Galijatovic, A., Tukey, R. H. (2005). Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest. Mol. Pharmacol. 67: 1247-1256 [Abstract] [Full Text]  
  • Zheng, W., Jefcoate, C. R. (2005). Steroidogenic Factor-1 Interacts with cAMP Response Element-Binding Protein to Mediate cAMP Stimulation of CYP1B1 via a Far Upstream Enhancer. Mol. Pharmacol. 67: 499-512 [Abstract] [Full Text]  
  • Fowler, A. M., Alarid, E. T. (2004). Dynamic Control of Nuclear Receptor Transcription. Sci Signal 2004: pe51-pe51 [Abstract] [Full Text]  
  • Gouedard, C., Barouki, R., Morel, Y. (2004). Dietary Polyphenols Increase Paraoxonase 1 Gene Expression by an Aryl Hydrocarbon Receptor-Dependent Mechanism. Mol. Cell. Biol. 24: 5209-5222 [Abstract] [Full Text]